COX10 and hyperinsulinemic hypoglycemia, familial, 4: BZF, which has been successfully employed in patients with defects of mitochondrial beta-oxidation, was shown to be effective also in a mouse model of COX deficiency due to COX10 mutations [14], and in cells of patients with COX deficiency due to COX10 mutation and with unknown defects.